Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
760
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
-3.06M
-
Total reported value, excl. options
-
$19.3B
-
Value change
-
-$327M
-
Put/Call ratio
-
0.7
-
Number of buys
-
317
-
Number of sells
-
-344
-
Price
-
$112.71
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2017
872 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q4 2017.
Edwards Lifesciences Corp - Common Stock (EW) has 760 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
of 590M outstanding shares and own 29.03% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (21.3M shares), BlackRock Inc. (15.4M shares), STATE STREET CORP (8.71M shares), Bank of New York Mellon Corp (7.58M shares), SANDS CAPITAL MANAGEMENT, LLC (6.96M shares), WELLINGTON MANAGEMENT GROUP LLP (6.56M shares), ALLIANCEBERNSTEIN L.P. (6.26M shares), AMERIPRISE FINANCIAL INC (3.8M shares), BROWN ADVISORY INC (3.75M shares), and NORGES BANK (3.24M shares).
This table shows the top 760 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.